238 filings
Page 4 of 12
SC 13G
bwvybl63zb6m4dd4
14 Feb 23
REVELATION BIOSCIENCES / AXA IM Prime Impact Master Fund I SCA SICAV-RAIF ownership change
12:39pm
5
bfse88 h2
14 Feb 23
REVELATION BIOSCIENCES / Investment Managers Paris AXA ownership change
12:28pm
8-K
gutcm1fhifi
13 Feb 23
Revelation Biosciences Inc. Announces Pricing of $15.6 Million Public Offering
5:30pm
424B3
szlg0iu rgmd0
10 Feb 23
Prospectus supplement
5:35pm
EFFECT
sn7kwq3
10 Feb 23
Notice of effectiveness
12:15am
S-1MEF
sj5 zyzyhk324w
9 Feb 23
Registration of additional securities for an S-1
9:37am
SC 13G/A
cjbzc8
6 Feb 23
REVELATION BIOSCIENCES / Weiss Asset Management ownership change
2:39pm
CORRESP
uiu7l
6 Feb 23
Correspondence with SEC
12:00am
CORRESP
ntwo3i7svbs
1 Feb 23
Correspondence with SEC
12:00am
8-K
dykj hq5s
31 Jan 23
Results of Special Meeting of Stockholders
5:09pm
SC 13G/A
kqoc lgo4e3vteab
31 Jan 23
REVELATION BIOSCIENCES / Linden Capital ownership change
3:31pm
DEFA14A
3wwtg65tlkvmykc7
13 Jan 23
Additional proxy soliciting materials
4:29pm
25-NSE
faw57sj 3m7
13 Jan 23
Exchange delisting
4:20pm
8-K
4da59ji5lp5n
10 Jan 23
Developing innovative therapeutics to address unmet needs Corporate Presentation / January 2023 www.revbiosciences.com
4:07pm
8-K
i5j064af
10 Jan 23
Revelation Biosciences Inc. Announces Pricing of Upcoming Automatic Unit Separation
4:02pm
8-K
mph52hu
21 Dec 22
Entry into a Material Definitive Agreement
4:11pm